Literature DB >> 21283123

Metformin or thiazolidinedione therapy in PCOS?

Anjali Grover, Maria A Yialamas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21283123     DOI: 10.1038/nrendo.2011.16

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

Review 1.  Polycystic ovary syndrome.

Authors:  David A Ehrmann
Journal:  N Engl J Med       Date:  2005-03-24       Impact factor: 91.245

2.  Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome.

Authors:  C Ortega-González; S Luna; L Hernández; G Crespo; P Aguayo; G Arteaga-Troncoso; A Parra
Journal:  J Clin Endocrinol Metab       Date:  2004-12-14       Impact factor: 5.958

3.  Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis.

Authors:  X-J Li; Y-X Yu; C-Q Liu; W Zhang; H-J Zhang; B Yan; L-Y Wang; S-Y Yang; S-H Zhang
Journal:  Clin Endocrinol (Oxf)       Date:  2011-03       Impact factor: 3.478

4.  Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial.

Authors:  R Azziz; D Ehrmann; R S Legro; R W Whitcomb; R Hanley; A G Fereshetian; M O'Keefe; M N Ghazzi
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

5.  Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

Authors:  D A Ehrmann; R B Barnes; R L Rosenfield; M K Cavaghan; J Imperial
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

6.  Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome.

Authors:  Teimuraz Apridonidze; Paulina A Essah; Maria J Iuorno; John E Nestler
Journal:  J Clin Endocrinol Metab       Date:  2004-12-28       Impact factor: 5.958

7.  Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome.

Authors:  Richard S Legro; Huiman X Barnhart; William D Schlaff; Bruce R Carr; Michael P Diamond; Sandra A Carson; Michael P Steinkampf; Christos Coutifaris; Peter G McGovern; Nicholas A Cataldo; Gabriella G Gosman; John E Nestler; Linda C Giudice; Phyllis C Leppert; Evan R Myers
Journal:  N Engl J Med       Date:  2007-02-08       Impact factor: 91.245

Review 8.  Metformin in polycystic ovary syndrome: systematic review and meta-analysis.

Authors:  Jonathan M Lord; Ingrid H K Flight; Robert J Norman
Journal:  BMJ       Date:  2003-10-25

9.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Authors: 
Journal:  Fertil Steril       Date:  2004-01       Impact factor: 7.329

10.  Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome.

Authors:  J E Nestler; D J Jakubowicz; W S Evans; R Pasquali
Journal:  N Engl J Med       Date:  1998-06-25       Impact factor: 91.245

  10 in total
  1 in total

1.  Metformin associated lactic acidosis in Auckland City Hospital 2005 to 2009.

Authors:  Imad Haloob; Janak R de Zoysa
Journal:  World J Nephrol       Date:  2016-07-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.